Multivariate predictors of blood product use in cardiac surgery.

OBJECTIVE To determine factors associated with an increased risk of post-cardiopulmonary bypass (CPB) blood product usage in adult cardiac surgical patients. DESIGN Prospective observational study. SETTING Academic hospital. PARTICIPANTS Patients undergoing cardiac surgery with CPB were studied over a 7-month period. INTERVENTIONS The outcomes studied were receipt of more than 2 U of packed red blood cells (PRBCs), receipt of any other blood component products (cryoprecipitate, fresh-frozen plasma [FFP], or platelets), or surgical re-exploration for bleeding. Preoperative and intraoperative risk factors for bleeding were analyzed. MEASUREMENTS AND MAIN RESULTS Increased age and preoperative creatinine level, low body surface area, preoperative hematocrit, nonelective surgery, lower temperature on bypass, and duration of bypass were associated with an increased risk of transfusion of >2 U of PRBCs. Low body surface area, repeat surgery, nonelective surgery, and CPB time were associated with transfusion of platelets, fresh-frozen plasma, or cryoprecipitate and/or surgical re-exploration. The following factors were associated with neither transfusion of more than 2 U of PRBC nor transfusion of platelets, FFP or cryoprecipitate, or surgical re-exploration: gender, preoperative international normalized ratio, preoperative antiplatelet medications, and preoperative intravenous heparin. CONCLUSION Therapies aimed at reducing transfusion of blood products should be aimed at those patients with low body surface areas, baseline anemia, and those undergoing long or repeat surgeries.

[1]  S J Pocock,et al.  Randomized trials or observational tribulations? , 2000, The New England journal of medicine.

[2]  G. Nuttall,et al.  Comparison of Blood-conservation Strategies in Cardiac Surgery Patients at High Risk for Bleeding , 2000, Anesthesiology.

[3]  S. Bratton,et al.  Factors associated with blood loss and blood product transfusions: a multivariate analysis in children after open-heart surgery. , 1999, Anesthesia and analgesia.

[4]  C. R. Smith,et al.  Management of bleeding complications in redo cardiac operations. , 1998, The Annals of thoracic surgery.

[5]  R. Wenzel,et al.  The Epidemiology of Hemorrhage Related to Cardiothoracic Operations , 1998, Infection Control & Hospital Epidemiology.

[6]  N. Altorki,et al.  Cardiac operations in patients with cirrhosis. , 1998, The Annals of thoracic surgery.

[7]  A. Harken,et al.  On “Surgical Treatment of Diastolic Dysfunction” by Brian S. Cain, M.D. and Alden H. Harken, M.D. , 1997 .

[8]  G. Silvay,et al.  Hemostasis in aortic and cardiothoracic surgery. , 1997, Journal of cardiac surgery.

[9]  M. Janssens,et al.  Treatment of excessive mediastinal bleeding after cardiopulmonary bypass. , 1996, The Annals of thoracic surgery.

[10]  R. McCarthy,et al.  Aspirin Does Not Increase Allogeneic Blood Transfusion in Reoperative Coronary Artery Surgery , 1996, Anesthesia and analgesia.

[11]  M. Newman,et al.  Maintenance of Therapeutic Plasma Aprotinin Levels During Prolonged Cardiopulmonary Bypass Using a Large-Dose Regimen , 1996, Anesthesia and Analgesia.

[12]  W. Hauck,et al.  Changes in blood coagulation during and following cardiopulmonary bypass: lack of correlation with clinical bleeding. , 1996, American journal of clinical pathology.

[13]  D. Reich,et al.  Tranexamic Acid Reduces Transfusions and Mediastinal Drainage in Repeat Cardiac Surgery , 1996, Anesthesia and analgesia.

[14]  C. Hogue,et al.  Factors Associated with Excessive Postoperative Blood Loss and Hemostatic Transfusion Requirements: A Multivariate Analysis in Cardiac Surgical Patients , 1996, Anesthesia and analgesia.

[15]  E. Spitznagel,et al.  The impact of heparin concentration and activated clotting time monitoring on blood conservation. A prospective, randomized evaluation in patients undergoing cardiac operation. , 1995, The Journal of thoracic and cardiovascular surgery.

[16]  S. Bélisle,et al.  Natural and synthetic antifibrinolytics in adult cardiac surgery: efficacy, effectiveness and efficiency , 1994, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

[17]  S. Khuri,et al.  Hematologic changes during and after cardiopulmonary bypass and their relationship to the bleeding time and nonsurgical blood loss. , 1992, The Journal of thoracic and cardiovascular surgery.

[18]  M. Carrier,et al.  The stratification of cardiac surgical procedures according to use of blood products: a retrospective analysis of 1480 cases , 1991, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

[19]  L. Harker,et al.  Bleeding complications associated with cardiopulmonary bypass. , 1990, Blood.

[20]  J. Caprini,et al.  Decreased Platelet Number and Function and Increased Fibrinolysis Contribute to Postoperative Bleeding in Cardiopulmonary Bypass Patients , 1988, Thrombosis and Haemostasis.